11.20 USD
▲+1.74+3.90%
盘后 10.40 -3.53%
2026-08-03
市值
$497.87M
市盈率
—
EPS
-2.39
股息率
—
52 周区间
4.12 – 25.96
成交量
2.37M
Beta
—
目标价
39.88
52W 低 4.1252W 高 25.96
价格走势
公司简介
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular e...